Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study-Reference-Cited by-同舟云学术

Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study

Published:2021-10 Issue:10 Volume:9 Page:1154-1164
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Lu Shun,Fang Jian,Li Xingya,Cao Lejie,Zhou Jianying,Guo Qisen,Liang Zongan,Cheng Ying,Jiang Liyan,Yang Nong,Han Zhigang,Shi Jianhua,Chen Yuan,Xu Hua,Zhang Helong,Chen Gongyan,Ma Rui,Sun Sanyuan,Fan Yun,Li Jing,Luo Xian,Wang Linfang,Ren Yongxin,Su Weiguo

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Approaches to tumor classification in pulmonary sarcomatoid carcinoma;Baldovini;Lung Cancer (Auckl),2019

2. Sarcomatoid carcinoma of the lung: the Mayo Clinic experience in 127 patients;Maneenil;Clin Lung Cancer,2018

3. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis;Martin;Ann Thorac Surg,2007

4. Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung;Ung;Clin Lung Cancer,2016

5. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma;Vieira;J Thorac Oncol,2013

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology;Lung Cancer;2024-10

2. Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Undergoing Concomitant Hemodialysis for Renal Failure: A Case Report;CLIN LUNG CANCER;2024

3. Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer;CLIN LUNG CANCER;2024

4. Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors;European Journal of Cancer;2024-09

5. Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study;The Lancet Respiratory Medicine;2024-09